2016. ECRD Conference – The Role of COAs in the Drug Approval Process of Products for the Treatment of Duchenne Muscular Dystrophy (USA and Europe)

Arnould B, Benmedjahed K, Acquadro C. The Role of COAs in the Drug Approval Process of Products for the Treatment of Duchenne Muscular Dystrophy (USA and Europe). Poster #40. Presented at: 8th ECRD Conference; May 26-28, 2016; Edinburgh, UK.